Withdrawal and Re-treatment with Filgotinib in Ulcerative Colitis: Post Hoc Analyses of the Phase 2b/3 SELECTION and SELECTIONLTE StudiesOriginal Article Published on 2024-01-042024-09-05 Journal: Journal of Crohn's and Colitis [Category] update2024, [키워드] filgotinib re-treatment ulcerative colitis [DOI] 10.1093/ecco-jcc/jjad123 PMC 바로가기 [Article Type] Original Article
Discontinuation of Nucleos(t)ide Analog treatment in HBeAg-Negative Non-Cirrhotic Chronic Hepatitis B Patients: Real-Life Data of 20 Yearsarticle Published on 2023-11-012024-09-05 Journal: The Turkish Journal of Gastroenterology [Category] update2024, [키워드] Discontinuation hepatitis B re-treatment Relapse Treatment [DOI] 10.5152/tjg.2023.22823 PMC 바로가기 [Article Type] article
Efficacy and Safety of Tofacitinib Re-treatment for Ulcerative Colitis After Treatment Interruption: Results from the OCTAVE Clinical TrialsOriginal Article Published on 2021-11-212024-09-04 Journal: Journal of Crohn's and Colitis [Category] 대상포진, [키워드] re-treatment Tofacitinib ulcerative colitis [DOI] 10.1093/ecco-jcc/jjab065 PMC 바로가기 [Article Type] Original Article
The sequence of disease-modifying therapies in relapsing multiple sclerosis: safety and immunologic considerationsReview Published on 2017-09-062024-09-02 Journal: Journal of Neurology [Category] 대상포진, [키워드] multiple sclerosis re-treatment selection for treatment Therapeutic Drug Monitoring Treatment effectiveness [DOI] 10.1007/s00415-017-8594-9 PMC 바로가기 [Article Type] Review
Outcomes of re-treatment with first-line trastuzumab plus a taxane in HER2 positive metastatic breast cancer patients after (neo)adjuvant trastuzumab: A prospective multicenter studyClinical Research Paper Published on 2016-08-022024-09-02 Journal: Oncotarget [Category] 대상포진, [키워드] (neo)adjuvant trastuzumab human epidermal growth factor receptor 2 (HER2) Metastatic breast cancer re-treatment Trastuzumab [DOI] 10.18632/oncotarget.9331 PMC 바로가기 [Article Type] Clinical Research Paper